Dean Petkanas - Net Worth and Insider Trading

Dean Petkanas Net Worth

The estimated net worth of Dean Petkanas is at least $6,945 dollars as of 2024-05-16. Dean Petkanas is the CEO, 10% Owner of Neuropathix Inc and owns about 23,149,029 shares of Neuropathix Inc (NPTX) stock worth over $6,945. Details can be seen in Dean Petkanas's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dean Petkanas has not made any transactions after 2022-06-09 and currently still holds the listed stock(s).

Transaction Summary of Dean Petkanas

To

Dean Petkanas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dean Petkanas owns 1 companies in total, including Neuropathix Inc (NPTX) .

Click here to see the complete history of Dean Petkanas’s form 4 insider trades.

Insider Ownership Summary of Dean Petkanas

Ticker Comapny Transaction Date Type of Owner
NPTX Neuropathix Inc 2022-06-09 director & 10 percent owner & Chief Executive Officer

Dean Petkanas Latest Holdings Summary

Dean Petkanas currently owns a total of 1 stock. Dean Petkanas owns 23,149,029 shares of Neuropathix Inc (NPTX) as of June 9, 2022, with a value of $6,945.

Latest Holdings of Dean Petkanas

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NPTX Neuropathix Inc 2022-06-09 23,149,029 0.00 6,945

Holding Weightings of Dean Petkanas


Dean Petkanas Form 4 Trading Tracker

According to the SEC Form 4 filings, Dean Petkanas has made a total of 4 transactions in Neuropathix Inc (NPTX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Neuropathix Inc is the sale of 320,000 shares on June 9, 2022, which brought Dean Petkanas around $6,400.

Insider Trading History of Dean Petkanas

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dean Petkanas Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dean Petkanas Ownership Network

Ownership Network List of Dean Petkanas

No Data

Ownership Network Relation of Dean Petkanas


Dean Petkanas Owned Company Details

What does Neuropathix Inc do?

Who are the key executives at Neuropathix Inc?

Dean Petkanas is the director & 10 percent owner & Chief Executive Officer of Neuropathix Inc. Other key executives at Neuropathix Inc include 10 percent owner Medical Marijuana, Inc. , Chief Financial Officer Mark Corrao , and Chief Scientific Officer William Kinney .

Neuropathix Inc (NPTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neuropathix Inc (NPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neuropathix Inc (NPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neuropathix Inc (NPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Neuropathix Inc Insider Transactions

No Available Data

Dean Petkanas Mailing Address

Above is the net worth, insider trading, and ownership report for Dean Petkanas. You might contact Dean Petkanas via mailing address: 3805 Old Easton Road, Doylestown Pa 18902.

Discussions on Dean Petkanas

No discussions yet.